SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Markets are reacting to a combination of escalating Middle East conflict, rising oil prices, and stronger-than-expected August jobs data that has shifted Fed rate expectations. Traders are particularly focused on the upcoming inflation reports to gauge whether the Federal Reserve will proceed with a rate hike in the coming weeks.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders react to positive management commentary from recent industry conferences regarding the company's path to profitability and the potential of its TIL cell therapy platform. Community discussion is heavily focused on anticipating upcoming Phase 2 NSCLC data and potential guidance updates, with many investors anticipating institutional accumulation and future price appreciation.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending as traders react to a sharp pullback in natural gas prices following news of upcoming major maintenance at the Freeport LNG facility, which has overshadowed concerns about extreme heat and supply constraints. While some investors view the decline as an opportunity to scale into positions, others highlight the structural decay inherent in the leveraged ETF and warn against long-term holding during the current shoulder season.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are showing high volatility following a Federal Reserve interest rate hike, with traders debating whether the central bank's hawkish shift and 'higher-for-longer' outlook signal a policy mistake or a necessary move to combat persistent inflation. The community remains deeply divided, characterized by heavy bearish sentiment and intense speculation over whether overnight price recoveries represent a sustainable trend or a 'bull trap' orchestrated by algorithmic trading.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy shares experienced a sharp rebound after an initial sell-off caused by a fiscal 2026 guidance cut and production delays at its Houston manufacturing facility. While investors were initially alarmed by the increased EBITDA loss projections, sentiment shifted as the community focused on the company's record backlog, strong demand from hyperscalers for energy storage, and long-term scaling potential as new manufacturing plants reach full capacity.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending due to significant community discussion surrounding an $8 billion long-term supply agreement with Generac to provide backup power generators for data centers, which traders view as a bullish validation of the company's commitment to AI-driven infrastructure. While sentiment remains divided due to broader market volatility and concerns over capital expenditure, many investors see the deal as a positive catalyst for long-term growth.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are currently receiving attention as traders debate the stock's consolidation phase, with many arguing that current price levels represent a deep-value opportunity based on strong fundamentals and growth projections despite short-term market volatility. Sentiment remains polarized between bulls who believe the stock is being strategically accumulated for a future rally and bears pointing to technical resistance levels, analyst target cuts, and macro concerns as evidence of a continued downtrend.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund is trending as traders analyze the impact of Fed interest rate policy, including expectations for rate hikes and ongoing monetary tightening, on the greenback. The community is also closely monitoring the dollar's performance in relation to precious metals and global currency fluctuations against other major currencies.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is experiencing significant volatility and downward price pressure, with traders debating whether this is a temporary sentiment shift tied to broader market conditions and related brokerage sectors or indicative of fundamental concerns. Despite recent strong quarterly earnings and growth initiatives, community discussion remains heavily divided between those viewing the decline as a buying opportunity and those expressing frustration over persistent insider selling and lack of sustained upward momentum.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

GoldCoin is currently trending due to community discussions surrounding its potential for long-term investment growth, despite limited market liquidity and occasional debates comparing its performance to other digital assets. Traders remain focused on its speculative price action and potential for future adoption within the crypto space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Exelixis (EXEL) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

EXEL Stock Slides After FDA Adds Three Months To Cancer Drug Review — William Blair Sees More Swings In Near Term

Equity

The FDA told Exelixis on Thursday that it had extended the review of a new drug application for zanzalintinib plus Roche’s Tecentriq in patients whose colorectal cancer has spread. 

Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In

FDA extends Exelixis NDA review for zanzalintinib to March 2027. Analyst evaluates stock volatility and revenue outlook.read more...

Exelixis (EXEL) Up 13.3% Since Last Earnings Report: Can It Continue?

Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September

Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in September: Wells Fargo 21st Annual Healthcare Conference: Exelixis is scheduled to present at 11:00 a.m. ET / 8:00 a.m. PT on Tuesday, September 8 in...

Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories

Exelixis, Inc. (Nasdaq: EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) vs. MSN Laboratories Private Limited et al. (MSN), Civil Action No. 22-00228 (Consolidated), the U.S. Court of Appeals for the Federal Circuit (Appeal No. 25-1236) has affirmed a key portion of the 2024...

Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term

Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm PR Newswire NEW YORK, Aug. 19, 2026 NEW YORK, Aug. 19, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain...

Here's Why Exelixis (EXEL) is a Strong Value Stock

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Exelixis Inc

Bearish Sentiment

A - Strong, decisive leadership

B - Solid, but room to improve

C - Mixed, still figuring it out

D/F - Poor communication and execution

Kevin Warsh has served as Federal Reserve Chair since May 2026, following one of the most divisive Senate confirmations in Fed history, and just delivered the Fed's first rate hike since 2023. How do you grade Kevin Warsh's performance as Fed chair so far? Vote and explain your reasoning in the comments.

Kevin Warsh has been Fed chair since May. How do you grade his performance so far?

Current Price	$56.78
Prev Close	$56.90
Open	$57.04
Dividend Yield	0.00%
50-Day Moving Average	$55.32
Beta	0.49
Avg. Volume	2.59M
PE Ratio	17.83

52-Week High	$59.72
52-Week Low	$33.76
Market Capitalization	$14.1B
EPS (Annual)	$2.78
Price to Book	7.66
Revenue Per Employee	$2.15M

Feed

News

Sentiment

Earnings

Fundamentals

Info

EXEL Fundamentals